# Clinical trials recruiting in Hawaii: 225 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 225 trials recruiting or not yet recruiting with a site in Hawaii, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Hawaii: 225 rows for $11.25, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/hawaii

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 225
- Recruiting or not yet: 225
- Read on: November 19, 2026

## Trials

The 25 newest of 225, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07938294 | Sotatercept in the Treatment of Methamphetamine-Associated Pulmonary Arterial Hypertension | Oregon Health and Science University | Phase 4 | Not yet recruiting | Pulmonary Arterial Hypertension (PAH), Methamphetamine Use Disorder | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938294) |
| October 28, 2026 | NCT07901751 | Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT) | Ray Therapeutics, Inc. | Phase 2/3 | Recruiting | Retinitis Pigmentosa (RP), Inherited Retinal Diseases | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901751) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 19, 2026 | NCT07881458 | A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881458) |
| October 19, 2026 | NCT07881432 | A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity | 2,115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881432) |
| October 13, 2026 | NCT07869836 | BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial... | SystImmune Inc. | Phase 3 | Recruiting | Urothelial Cancer, Metastatic Urothelial Cancer, Bladder Cancer, Bladder Cancer (BC), Bladder (Urothelial, Transitional... | 520 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869836) |
| October 8, 2026 | NCT07866053 | AI-Enabled Wearable Monitoring for Detection of Postpartum Depression and Anxiety | University of Hawaii | Observational | Not yet recruiting | Postpartum Depression (PPD), Postpartum Anxiety | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07866053) |
| September 14, 2026 | NCT07817251 | Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema | Novo Nordisk A/S | Phase 3 | Recruiting | Diabetes Mellitus, Type 2 | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817251) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| August 18, 2026 | NCT07770841 | Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight | Novo Nordisk A/S | Phase 3 | Recruiting | Overweight, Obesity | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770841) |
| August 10, 2026 | NCT07754461 | A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar | Boehringer Ingelheim | Phase 3 | Recruiting | Type 2 Diabetes | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754461) |
| August 4, 2026 | NCT07745504 | A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight | Novo Nordisk A/S | Phase 3 | Recruiting | Overweight, Obesity | 285 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745504) |
| July 28, 2026 | NCT07730450 | A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age | BioNTech SE | Phase 4 | Recruiting | COVID-19 Vaccines | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07730450) |
| July 23, 2026 | NCT07723976 | A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE | Jazz Pharmaceuticals | Phase 3 | Recruiting | Developmental and Epileptic Encephalopathy (DEE) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07723976) |
| July 23, 2026 | NCT07723963 | A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy | Jazz Pharmaceuticals | Phase 2/3 | Recruiting | Juvenile Myoclonic Epilepsy | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07723963) |
| July 22, 2026 | NCT07720271 | AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight | Novo Nordisk A/S | Phase 3 | Recruiting | Overweight, Obesity | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07720271) |
| July 21, 2026 | NCT07717411 | A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease | Hoffmann-La Roche | Phase 3 | Recruiting | Alzheimer's Disease | 1,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717411) |
| July 17, 2026 | NCT07711002 | Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy... | AstraZeneca | Phase 3 | Recruiting | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | 1,330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711002) |
| July 15, 2026 | NCT07705945 | Using Telehealth to Improve Musculoskeletal Care Through Expanded Physical Therapy Access | Brooke Army Medical Center | Not applicable | Not yet recruiting | Musculoskeletal Pain | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705945) |
| July 6, 2026 | NCT07684235 | Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION) | Amgen | Phase 3 | Recruiting | Obesity, Overweight | 3,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684235) |
| June 17, 2026 | NCT07654361 | Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Phase 3 | Recruiting | Obesity, Overweight, Chronic Weight Management | 3,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07654361) |
| June 5, 2026 | NCT07630649 | Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration | Adverum Biotechnologies, Inc. | Phase 2 | Recruiting | Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630649) |
| May 18, 2026 | NCT07594119 | Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures | Rapport Therapeutics Inc. | Phase 3 | Recruiting | Focal Seizure, Epilepsy, Focal Epilepsy | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07594119) |
| May 8, 2026 | NCT07575399 | Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in... | Amgen | Phase 3 | Recruiting | Obesity or Overweight | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575399) |
| May 5, 2026 | NCT07567001 | A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity | Novo Nordisk A/S | Phase 3 | Recruiting | Obesity, Heart Failure | 5,610 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07567001) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Kapiolani Medical Center for Women and Children | Honolulu | 65 |
| Hawaii Cancer Care Inc - Waterfront Plaza | Honolulu | 38 |
| Queen's Medical Center | Honolulu | 38 |
| Queen's Cancer Center - Kuakini | Honolulu | 35 |
| Pali Momi Medical Center | ‘Aiea | 35 |
| Hawaii Cancer Care - Westridge | ‘Aiea | 35 |
| Kaiser Permanente Moanalua Medical Center | Honolulu | 34 |
| Straub Clinic and Hospital | Honolulu | 34 |
| Queen's Cancer Cenrer - POB I | Honolulu | 33 |
| University of Hawaii Cancer Center | Honolulu | 32 |
| The Queen's Medical Center - West Oahu | ‘Ewa Beach | 30 |
| Wilcox Memorial Hospital and Kauai Medical Clinic | Lihue | 20 |
| Queen's Cancer Center - Pearlridge | ‘Aiea | 20 |
| Kuakini Medical Center | Honolulu | 19 |
| The Cancer Center of Hawaii-Liliha | Honolulu | 19 |
| Tripler Army Medical Center | Honolulu | 17 |
| The Cancer Center of Hawaii-Pali Momi | ‘Aiea | 17 |
| Castle Medical Center | Kailua | 11 |
| The Queen's Medical Center | Honolulu | 10 |
| Hawaii Diagnostic Radiology Services LLC | Honolulu | 9 |
| Straub Medical Center - Kahului Clinic | Kahului | 9 |
| Hawaii Cancer Care Inc-Liliha | Honolulu | 8 |
| Hawaii Pacific Neuroscience | Honolulu | 8 |
| Straub Pearlridge Clinic | ‘Aiea | 7 |
| East-West Medical Research Institute | Honolulu | 6 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 4 |
| Phase 1/2 | 5 |
| Phase 2 | 36 |
| Phase 2/3 | 10 |
| Phase 3 | 91 |
| Phase 4 | 5 |
| Not applicable | 42 |
| Observational | 31 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Obesity | 18 |
| Overweight | 16 |
| Breast Neoplasms | 16 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Neoplasms | 15 |
| Lung Neoplasms | 11 |
| Diabetes Mellitus, Type 2 | 10 |
| Neoplasm Metastasis | 9 |
| Hypertension | 7 |
| Neuroblastoma | 7 |
| Ovarian Neoplasms | 7 |
| Pancreatic Neoplasms | 7 |
| Leukemia, Myeloid, Acute | 6 |
| Colorectal Neoplasms | 6 |
| Prostatic Neoplasms | 6 |
| Osteosarcoma | 5 |
| Colonic Neoplasms | 5 |
| Endometrial Neoplasms | 5 |
| Burkitt Lymphoma | 5 |
| Heart Failure | 4 |
| Alzheimer Disease | 4 |
| Carcinoma | 4 |
| Carcinoma, Hepatocellular | 4 |
| Melanoma | 4 |
| Down Syndrome | 3 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 25 |
| Children's Oncology Group | 17 |
| University of Hawaii | 14 |
| NRG Oncology | 12 |
| SWOG Cancer Research Network | 10 |
| Alliance for Clinical Trials in Oncology | 10 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 8 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 8 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 6 |
| Queen's Medical Center | 5 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 4 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 4 |
| [Jazz Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/jazz-pharmaceuticals) | 3 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 3 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 2 |
| Vanderbilt University Medical Center | 2 |
| Milton S. Hershey Medical Center | 2 |
| Brooke Army Medical Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| University of Rochester | 2 |
| Tripler Army Medical Center | 2 |
| EXoPERT | 2 |
| ECOG-ACRIN Cancer Research Group | 2 |
| [ACADIA Pharmaceuticals Inc.](https://specstream.ai/data/clinical-trials/company/acadia-pharmaceuticals-inc) | 2 |
| [Microvention-Terumo, Inc.](https://specstream.ai/data/clinical-trials/company/microvention-terumo-inc) | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Hawaii

- [Alternative medicine clinics in Hawaii, United States](https://specstream.ai/data/businesses/alternative-medicine-clinics/hawaii-united-states)
- [IT service companies in Hawaii, United States](https://specstream.ai/data/businesses/it-service-companies/hawaii-united-states)
- [Advertising agencies in Hawaii, United States](https://specstream.ai/data/businesses/advertising-agencies/hawaii-united-states)
- [IT companies in Hawaii, United States](https://specstream.ai/data/businesses/it-companies/hawaii-united-states)
- [Acupuncture clinics in Hawaii, United States](https://specstream.ai/data/businesses/acupuncture-clinics/hawaii-united-states)
- [Interior design firms in Hawaii, United States](https://specstream.ai/data/businesses/interior-design-firms/hawaii-united-states)
